SOURCE: PharmaFrontiers

August 16, 2005 16:13 ET

PharmaFrontiers to Present at Dallas, Texas Investor Conference

THE WOODLANDS, TX -- (MARKET WIRE) -- August 16, 2005 -- PharmaFrontiers Corp. (OTC BB: PFTR), a company involved in the development and commercialization of cell therapies, today announced that it will be a featured presenter at the Cinapsys Microcap Investor Conference August 24th in Dallas, Texas. The conference will be held at the Intercontinental Hotel, located at 15201 Dallas Pkwy., Addison, TX, 75001. The Conference begins at 9:00 a.m. For reservations please phone: 972-386-6000 and indicate the Cinapsys Conference.

The event, which spans 2 full days, is being sponsored by Securities Compliance Control, August Law Group, Hein & Associates, Market Wire, Continental Stock Transfer, Knobias, Cohen Research, Halter Financial, StreetIQ, Vintage Filings and other notable industry providers. PharmaFrontiers will present in a 20 minute session followed by a question and answer period. Shareholders and interested parties are encouraged to attend the event. More details are available at:

This event will be webcast live and on demand as well, at:

About PharmaFrontiers Corp.

PharmaFrontiers' strategy is to develop and commercialize cell therapies to treat several major disease areas such as cardiac and pancreatic conditions and Multiple Sclerosis. The company holds the exclusive worldwide license from the University of Chicago through its prime contractor relationship with Argonne National Laboratory for patents relating to the use of adult pluripotent stem cells derived from patients' own circulating blood. PharmaFrontiers also owns patented and proprietary individualized cell therapies that are in FDA Phase I/II human dose ranging clinical trials to evaluate their safety and effectiveness in treating MS.

About the Cinapsys Microcap Conference

The Cinapsys Microcap Conferences provide a concentrated forum where institutional and retail investors can meet and network with the executives of growth companies hand picked by Cinapsys staff. The conference will highlight approximately a dozen companies from industry groups including Energy, Technology, Business Services and more.

For information about the conference visit:

This press release contains "forward-looking statements," including statements about PharmaFrontiers' growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. These forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to PharmaFrontiers' ability to obtain additional funding, develop its stem cell technologies, achieve its operational objectives, and obtain patent protection for its discoveries, that may cause PharmaFrontiers' actual results to be materially different from any future results expressed or implied by such forward-looking statements. PharmaFrontiers undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information